UMGCCC Clinical Trials

  • More About Clinical Trials
  • Deciding to Enroll
  • Questions to Ask
  • For More Information
  • Research
  • Cancer Overviews
  • Treatment Programs
  • Physicians and Staff
Protocol SummaryBack To Search Instructions
Protocol No.SWOG1400IPrincipal InvestigatorScilla, Katherine
PhasePhase III
Age GroupAdult
TitleA Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-MAP Sub-Study)
Applicable Disease SitesLung
Drugs InvolvedIpilimumab (MDX-010
BMS-734016)
Nivolumab
StatusOpen (affiliates only)
Treatment TypeTreatment
ClinicalTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT02785952
ContactGreenebaum Cancer Center Maha Khalil, PhD Phone:410-328-5009
Pager:
Email:mkhalil@umm.edu
Back to Protocol Listing